Fujian Aonong Biological Technology Group Incorporation Limited (603363.SS)
CNY 3.57
(0.85%)
CNY 3.57
(0.85%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -3.65 Billion CNY | -197.55% |
| 2022 | -1.22 Billion CNY | 33.71% |
| 2021 | -1.85 Billion CNY | -286.28% |
| 2020 | 993.6 Million CNY | 890.08% |
| 2019 | 100.35 Million CNY | 233.12% |
| 2018 | 30.12 Million CNY | -72.14% |
| 2017 | 108.11 Million CNY | 18.32% |
| 2016 | 91.37 Million CNY | 170.53% |
| 2015 | 33.77 Million CNY | -20.98% |
| 2014 | 42.74 Million CNY | 71.04% |
| 2013 | 24.99 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -292.01 Million CNY | 87.63% |
| 2024 Q3 | -278.98 Million CNY | -12.5% |
| 2024 Q2 | -247.98 Million CNY | 15.08% |
| 2023 Q4 | -2.36 Billion CNY | -391.28% |
| 2023 FY | -3.65 Billion CNY | -197.55% |
| 2023 Q1 | -250.46 Million CNY | 47.1% |
| 2023 Q2 | -629.61 Million CNY | -151.38% |
| 2023 Q3 | -480.56 Million CNY | 23.67% |
| 2022 Q1 | -486.08 Million CNY | 52.2% |
| 2022 FY | -1.22 Billion CNY | 33.71% |
| 2022 Q3 | 150.28 Million CNY | 135.98% |
| 2022 Q4 | -473.5 Million CNY | -415.06% |
| 2022 Q2 | -417.64 Million CNY | 14.08% |
| 2021 Q3 | -340.26 Million CNY | -4.82% |
| 2021 Q4 | -1.01 Billion CNY | -198.89% |
| 2021 Q1 | 162.02 Million CNY | 129.13% |
| 2021 Q2 | -324.63 Million CNY | -300.36% |
| 2021 FY | -1.85 Billion CNY | -286.28% |
| 2020 Q4 | 70.71 Million CNY | -56.98% |
| 2020 Q2 | 186.85 Million CNY | 23.69% |
| 2020 FY | 993.6 Million CNY | 890.08% |
| 2020 Q1 | 151.06 Million CNY | 1436.62% |
| 2020 Q3 | 164.35 Million CNY | -12.04% |
| 2019 FY | 100.35 Million CNY | 233.12% |
| 2019 Q4 | -11.3 Million CNY | -159.29% |
| 2019 Q3 | 19.06 Million CNY | 378.13% |
| 2019 Q2 | 3.98 Million CNY | -77.1% |
| 2019 Q1 | 17.4 Million CNY | 1211.98% |
| 2018 Q2 | 2.76 Million CNY | -80.35% |
| 2018 Q4 | -1.56 Million CNY | -110.55% |
| 2018 Q3 | 14.84 Million CNY | 436.29% |
| 2018 FY | 30.12 Million CNY | -72.14% |
| 2018 Q1 | 14.08 Million CNY | -20.25% |
| 2017 FY | 108.11 Million CNY | 18.32% |
| 2017 Q1 | 23.54 Million CNY | -16.23% |
| 2017 Q2 | 40.67 Million CNY | 72.75% |
| 2017 Q3 | 26.24 Million CNY | -35.47% |
| 2017 Q4 | 17.65 Million CNY | -32.72% |
| 2016 Q4 | 28.1 Million CNY | 131.71% |
| 2016 FY | 91.37 Million CNY | 170.53% |
| 2016 Q3 | 12.12 Million CNY | 0.0% |
| 2015 FY | 33.77 Million CNY | -20.98% |
| 2014 FY | 42.74 Million CNY | 71.04% |
| 2013 FY | 24.99 Million CNY | 0.0% |